Skip to content
Screener

Perrigo Company PRGO Q2 2026 earnings

Reported August 5, 2026 · Before market open

Revenue$1.0BBeat by $7.3M
EPS$0.50Beat by $0.11
Revenue estimate$1.0B
EPS estimate$0.39
“We continued to execute our Three-S plan in the second quarter, strengthening areas of the business within our control, improving operational performance, streamlining our portfolio, and further reducing debt. While results were impacted by ongoing category softness and macroeconomic headwinds, we again drove market share gains as our broad portfolio of quality self-care products across all price points continues to resonate with consumers seeking value and affordability. We also took another important step in simplifying our portfolio by completing the previously announced sale of our Dermacosmetics business, and are continuing the strategic reviews of our Infant Formula and Oral Care businesses. We are becoming a more focused consumer self-care company, and are making progress in strengthening the underlying fundamentals of our business.”
Albert Manzone

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$991.5M
EPS estimate$0.52

Financials

Q2 2026

Income statement

See full
Revenue$1.0B-3.2%
Gross profit$313.9M-13.5%
Operating income$23.5M-48.2%
Net income$74.5M+987%
EPS (diluted)$0.53+983%

Balance sheet

See full
Cash & equivalents$399.7M-12.0%
Total debt$3.5B-10.3%
Total equity$2.5B-43.7%
Total assets$7.6B-24.6%

Cash flow

See full
CapEx$14.3M-25.5%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$1.88B-35.4%
Enterprise value$4.96B-21.7%
P/S0.5×-0.2×

Profitability

See full
Gross margin33.3%-2.5pp
Operating margin-37.7%-44.3pp
Net margin-41.9%-43.9pp

Returns & leverage

See full
Return on equity-49.6%-51.6pp
Debt / equity1.4×+0.5×
Current ratio2.3×0.0×

Segments

By product

See full
Upper Respiratory$178.4M-1.6%
Skin Health$161.8M—
Healthy Lifestyle$157.8M+2.0%
Pain & Sleep$124.6M—
Digestive Health$115.7M-3.4%

By segment

See full
Self Care$576.6M—
Specialty Care$226.6M—
Infant Formula$100.9M—

FAQ

When did Perrigo Company report Q2 2026 earnings?
Perrigo Company (PRGO) reported Q2 2026 earnings on August 5, 2026 before market open.
What were Perrigo Company's Q2 2026 revenue and EPS?
Perrigo Company reported revenue of $1.0B and eps of $0.50 for Q2 2026.
Did Perrigo Company beat estimates in Q2 2026?
Revenue beat the consensus estimate of $1.0B by $7.3M. EPS beat the consensus estimate of $0.39 by $0.11.
How did Perrigo Company's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.2% from $1.1B a year earlier and eps declined 12.3% from $0.57.
Where can I find Perrigo Company's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001585364-26-000143) and the 10-Q periodic report (0001585364-26-000145) directly on SEC EDGAR. The filing index links above go to sec.gov.